You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Caring for Patients With Advanced Basal Cell Carcinoma: Perspectives From the Interprofessional Team

  • Authors: Omid Hamid, MD; Vishal Patel, MD, FAAD, FACMS; Krista M. Rubin, MS, RN, FNP-BC
  • CME / ABIM MOC / CE Released: 1/5/2022
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 1/5/2023
Start Activity


Target Audience and Goal Statement

This activity is intended for oncologists, dermatologists, Mohs surgeons, nurses, nurse practitioners, and pharmacists.

The goal of this activity is to improve clinicians’ understanding and ability to manage patients with advanced basal cell carcinoma (BCC) as part of the interprofessional team.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Clinical trial data evaluating systemic therapy in the management of advanced BCC
  • Have greater competence related to
    • Personalizing of care for patients with advanced BCC
  • Demonstrate greater confidence in their ability to
    • Effectively coordinate care with members of the interprofessional team in order to optimize outcomes for patients with advanced BCC


Disclosures

As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Faculty

  • Omid Hamid, MD

    Chief of Research/Immuno-Oncology
    The Angeles Clinic and Research Institute, a Cedars-Sinai Affiliate
    Co-Director, Cutaneous Malignancy Program
    Los Angeles, California

    Disclosures

    Disclosure: Omid Hamid, MD, has the following relevant financial relationships:
    Advisor or consultant for: Aduro; Akeso; Amgen; BeiGene; BioAtla; Bristol Myers Squibb Company; Genentech; GlaxoSmithKline; Immunocore; Idera; Incyte; Janssen; Merck; NextCure; Novartis; Pfizer; Regeneron; Roche; Sanofi; Seagen Inc., formerly Seattle Genetics, Inc.; Tempus; Zelluna
    Speaker or a member of a speakers bureau for: Bristol Myers Squibb Company; Novartis; Pfizer; Sanofi; Regeneron
    Grants for clinical research from: Arcus; Aduro; Akeso; Amgen; BioAtla; Bristol Myers Squibb Company; CytomX; Exelixis; Genentech; GlaxoSmithKline; Immunocore; Idera; Incyte; Iovance; Merck; Merck Serono; Moderna; NextCure; Novartis; Pfizer; Regeneron; Roche; Seagen Inc., formerly Seattle Genetics, Inc.; Torque; Zelluna
    Other: Independent contractor for: Arcus; Aduro; Akeso; Amgen; BioAtla; Bristol Myers Squibb Company; CytomX; Exelixis; Genentech; GlaxoSmithKline; Immunocore; Idera; Incyte; Iovance; Merck; Merck Serono; Moderna; NextCure; Novartis; Pfizer; Regeneron; Roche; Seagen Inc., formerly Seattle Genetics, Inc.; Torque; Zelluna

  • Vishal Patel, MD, FAAD, FACMS

    Director of Cutaneous Oncology, GW Cancer Center
    Director of Dermatologic Surgery, GW Department of Dermatology
    Assistant Professor of Dermatology & Hematology/Oncology
    George Washington University School of Medicine & Health Sciences
    Washington, DC

    Disclosures

    Disclosure: Vishal Patel, MD, FAAD, FACMS, has the following relevant financial relationships:
    Advisor or consultant for: Almirall; Jounce; PHD Biosciences; Regeneron; Sanofi
    Speaker or a member of a speakers bureau for: Almirall; Regeneron; Sanofi
    Other: Independent contractor for: Almirall; Jounce; PHD Biosciences

  • Krista M. Rubin, MS, RN, FNP-BC

    Nurse Practitioner
    Center for Melanoma
    Massachusetts General Hospital Cancer Center
    Boston, Massachusetts

    Disclosures

    Disclosure: Krista M. Rubin, MS, RN, FNP-BC, has the following relevant financial relationships:
    Advisor or consultant for: Bristol Myers Squibb Company; Eisai; Merck

Editor

  • Lisa Cockrell, PhD

    Medical Education Director, Medscape, LLC 

    Disclosures

    Disclosure: Lisa Cockrell, PhD has disclosed no relevant financial relationships. 

CME, CE Reviewer/Nurse Planner

  • Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has disclosed no relevant financial relationships.

None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape designates this continuing education activity for 0.50 contact hour(s) (0.050 CEUs) (Universal Activity Number: UAN JA0007105-0000-21-603-H01-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Caring for Patients With Advanced Basal Cell Carcinoma: Perspectives From the Interprofessional Team

Authors: Omid Hamid, MD; Vishal Patel, MD, FAAD, FACMS; Krista M. Rubin, MS, RN, FNP-BCFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / ABIM MOC / CE Released: 1/5/2022

Valid for credit through: 1/5/2023

processing....

Educational Impact Challenge

The goal of this activity is to improve clinicians’ understanding and ability to manage patients with advanced basal cell carcinoma (BCC) as part of the interprofessional team.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print